Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
29.87
+1.20 (4.19%)
At close: Jan 29, 2026, 4:00 PM EST
29.56
-0.31 (-1.03%)
After-hours: Jan 29, 2026, 7:59 PM EST
Hims & Hers Health Revenue
Hims & Hers Health had revenue of $598.98M in the quarter ending September 30, 2025, with 49.16% growth. This brings the company's revenue in the last twelve months to $2.21B, up 78.02% year-over-year. In the year 2024, Hims & Hers Health had annual revenue of $1.48B with 69.33% growth.
Revenue (ttm)
$2.21B
Revenue Growth
+78.02%
P/S Ratio
2.89
Revenue / Employee
$1,350,616
Employees
1,637
Market Cap
6.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.48B | 604.51M | 69.33% |
| Dec 31, 2023 | 872.00M | 345.08M | 65.49% |
| Dec 31, 2022 | 526.92M | 255.04M | 93.81% |
| Dec 31, 2021 | 271.88M | 123.12M | 82.77% |
| Dec 31, 2020 | 148.76M | 66.20M | 80.18% |
| Dec 31, 2019 | 82.56M | 55.88M | 209.45% |
| Dec 31, 2018 | 26.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Viatris | 14.12B |
| Elanco Animal Health | 4.59B |
| Dr. Reddy's Laboratories | 3.85B |
| Amneal Pharmaceuticals | 2.93B |
| Neurocrine Biosciences | 2.68B |
| Lantheus Holdings | 1.53B |
| Alkermes | 1.52B |
| Prestige Consumer Healthcare | 1.11B |
HIMS News
- 11 hours ago - Hims & Hers Returns to the Big Game with a Message to All Americans: The Era of Health as a Luxury is Over - Business Wire
- 1 day ago - Hims & Hers: It's Time To Get Aggressive - Seeking Alpha
- 4 days ago - Hims & Hers Health: The Reset Nobody Expected - Seeking Alpha
- 8 days ago - Top 3 Health Care Stocks That Could Blast Off This Month - Benzinga
- 13 days ago - Looking For A Short Squeeze? 10 Stocks Ready To Rocket - Benzinga
- 17 days ago - Hims & Hers stock is crashing: will it rebound soon? - Invezz
- 20 days ago - Hims & Hers Health: Capitalizing On Healthcare Innovation - Seeking Alpha
- 21 days ago - Hims & Hers Growth Story Has A Lot To Prove In 2026 - Seeking Alpha